Equity Profile

INDV

Indivior Pharmaceuticals, Inc.

Health CarePharmaceuticals$4.5B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Indivior Pharmaceuticals, Inc. is a healthcare company focused on developing and commercializing innovative treatments for addiction and other mental health disorders....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its market presence and product adoption.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

INDV Q2-2026 Earnings Preview

Context

Company Snapshot

Indivior Pharmaceuticals, Inc. is a healthcare company focused on developing and commercializing innovative treatments for addiction and other mental health disorders. With a market cap of $5 billion, its work is particularly relevant as society increasingly recognizes the importance of mental health and addiction treatment.

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+68.40%

Avg Stock Reaction

+9.86%

Last Quarter Recap

In Q1-2026, Indivior reported an EPS of $0.96, significantly beating expectations of $0.64, which led to a 7.7% increase in stock price the following day. The company has consistently surprised on earnings, with a 100% beat rate over the last four quarters.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are high for Indivior as it has consistently exceeded earnings estimates in recent quarters. Investors are looking for continued strong performance, especially in EPS and revenue growth.

Bull Case

If Indivior continues its trend of beating earnings estimates, it could see a significant stock price increase, reflecting strong demand for its products and effective management.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this figure will be crucial in determining market reaction.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to gauge the company's market performance and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Indivior's ability to maintain its growth trajectory, especially given its recent strong performance in EPS.

Supporting Evidence

Indivior has a 100% EPS beat rate over the last four quarters, indicating strong operational execution.

The high implied volatility suggests that traders are expecting a significant move, which may not align with consensus expectations.

Key Risk

If EPS comes in below $0.80, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Indivior can maintain its impressive earnings momentum amid increasing competition and market challenges.

Bull Confirmed If

A reported EPS above $1.00 would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.80 would confirm the bear case, suggesting potential issues with growth or profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±20.61%

Historical Avg

±9.9%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±20.6% while INDV has averaged ±9.9% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

36.0%

Calls (1K)P/C Ratio: 0.24Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Indivior beats expectations, history suggests the stock could rise by approximately 9.86%, confirming strong demand for its products.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious sentiment among investors.

Miss

A miss could lead to a decline in stock price, with historical data suggesting an average drop of around 9.86%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market competition and pricing strategies.
3Insights into customer demand trends for addiction treatment products.
4Guidance on revenue expectations for the upcoming quarters.
5Any changes in regulatory environment impacting the business.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Indivior Pharmaceuticals, Inc. is a healthcare company focused on developing and commercializing innovative treatments for addiction and other mental health disorders....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its market presence and product adoption.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

INDV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+68.40%

Avg Stock Reaction

+9.86%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Indivior continues its trend of beating earnings estimates, it could see a significant stock price increase, reflecting strong demand for its products and effective management.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this figure will be crucial in determining market reaction.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to gauge the company's market performance and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Indivior's ability to maintain its growth trajectory, especially given its recent strong performance in EPS.

Supporting Evidence

Indivior has a 100% EPS beat rate over the last four quarters, indicating strong operational execution.

The high implied volatility suggests that traders are expecting a significant move, which may not align with consensus expectations.

Key Risk

If EPS comes in below $0.80, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Indivior can maintain its impressive earnings momentum amid increasing competition and market challenges.

Bull Confirmed If

A reported EPS above $1.00 would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.80 would confirm the bear case, suggesting potential issues with growth or profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±20.61%

Historical Avg

±9.9%

Pricing rich

The options market is pricing in a significant potential move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±20.6% while INDV has averaged ±9.9% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

36.0%

Calls (1K)P/C Ratio: 0.24Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Indivior beats expectations, history suggests the stock could rise by approximately 9.86%, confirming strong demand for its products.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious sentiment among investors.

Miss

A miss could lead to a decline in stock price, with historical data suggesting an average drop of around 9.86%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market competition and pricing strategies.
3Insights into customer demand trends for addiction treatment products.
4Guidance on revenue expectations for the upcoming quarters.
5Any changes in regulatory environment impacting the business.